Dramatic response of metaplastic breast cancer to chemo-immunotherapy

Abstract Frequent overexpression of programmed death-ligand 1 has recently been demonstrated in metaplastic breast cancer, which is a rare breast cancer subtype with limited treatment options. This report describes the clinical course of a patient with metastatic metaplastic breast cancer who had a...

Full description

Bibliographic Details
Main Author: Sylvia Adams
Format: Article
Language:English
Published: Nature Publishing Group 2017-03-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-017-0011-0